Home > Products > Pharmaceutical R&D Materials > Functional Building Blocks > 4-(3-(DIFLUOROMETHYL)-5-(3-FLUORO-4-METHOXYPHENYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE
4-(3-(DIFLUOROMETHYL)-5-(3-FLUORO-4-METHOXYPHENYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE structure, CAS 169590-41-4

4-(3-(DIFLUOROMETHYL)-5-(3-FLUORO-4-METHOXYPHENYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE

CAS Number169590-41-4

Synonymsderacoxib; 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide; 4-(3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide; 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide

Molecular FormulaC17H14F3N3O3S

Molecular Weight397.372

Purity96+%

Density1.5±0.1 g/cm3

Boiling Point575.5±60.0 °C at 760 mmHg

Melting Point

Flash Point

Appearancepowder

EINECS0

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-0134799 Purity: 96+%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 169590-41-4 ] Purity: 96+% SDS Specification MoL

Chemical & Physical Properties
CAS Number169590-41-4
Catalog No.2A-0134799
Chinese Name地拉考昔
Synonymsderacoxib; 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide; 4-(3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide; 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide
Molecular FormulaC17H14F3N3O3S
Molecular Weight397.372
Purity96+
Density1.5±0.1 g/cm3
Boiling Point575.5±60.0 °C at 760 mmHg
Appearancepowder
Storage Condition-20℃
ApplicationDeracoxib is a COX-2 selective inhibitor, a non-narcotic, non-steroidal anti-inflammatory compound.
EINECS0
HTC2935009090
UN(IATA)0
SMILESCOc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F
InChIInChI=1S/C17H14F3N3O3S/c1-26-16-7-2-10(8-13(16)18)15-9-14(17(19)20)22-23(15)11-3-5-12(6-4-11)27(21,24)25/h2-9,17H,1H3,(H2,21,24,25)
InChI KeyWAZQAZKAZLXFMK-UHFFFAOYSA-N
Use ofProperties Name deracoxib Synonym More Synonyms deracoxib Biological Activity Related Catalog Research Areas >> Inflammation/Immunology References [1]. Royals, S.R., et al., Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res, 2005. 66(11): p. 1961-7. [2]. Ustun Alkan, F., et al., The effects of piroxicam and deracoxib on canine mammary tumour cell line. ScientificWorldJournal, 2012. 2012: p. 976740. [3]. Bienhoff, S.E., et al., Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs. Vet Surg, 2012. 41(3): p. 336-44. [4]. McMillan, S.K., et al., Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc, 2011. 239(8): p. 1084-9. Chemical & Physical Properties Molecular Formula C17H14F3N3O3S Exact Mass 397.070801 PSA 95.59000 Index of Refraction 1.610 InChIKey WAZQAZKAZLXFMK-UHFFFAOYSA-N Storage condition -20℃ Safety Information HS Code 2935009090 Synthetic Route 4,4-difluoro-1-... CAS#:170570-77-1 CAS#:169590-41-4 Literature: G.D. Searle and Co. Patent: US5760068 A1, 1998 ; 4-Hydrazinobenz... CAS#:17852-52-7 4,4-difluoro-1-... CAS#:170570-77-1 CAS#:169590-41-4 Literature: G. D. Searle and Co. Patent: US6342510 B1, 2002 ; Location in patent: Page column 28 - 29 ; ethyldifluoracetat CAS#:454-31-9 3′-Fluoro-4′-me... CAS#:455-91-4 CAS#:169590-41-4 Literature: US5892053 A1, ; Precursor & DownStream Precursor 4 CAS#:170570-77-1 4,4-difluoro-1-... CAS#:17852-52-7 4-Hydrazinobenz... CAS#:454-31-9 ethyldifluoracetat CAS#:455-91-4 3′-Fluoro-4′-me... DownStream 0
Tax Rebate9.0%
SupervisionNone MFN tariff: 6.5% Ordinary tariff: 35.0%
Transport InfoProduct name: Summary 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA